1. Home
  2. HSIC vs TECH Comparison

HSIC vs TECH Comparison

Compare HSIC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$71.86

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$50.89

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSIC
TECH
Founded
1932
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.2B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
HSIC
TECH
Price
$71.86
$50.89
Analyst Decision
Buy
Strong Buy
Analyst Count
14
12
Target Price
$84.50
$73.09
AVG Volume (30 Days)
1.4M
2.2M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
0.62%
EPS Growth
7.21
N/A
EPS
3.27
0.49
Revenue
$13,201,995,000.00
$1,219,635,000.00
Revenue This Year
$6.14
$2.49
Revenue Next Year
$3.64
$6.40
P/E Ratio
$22.25
$105.65
Revenue Growth
5.94
5.23
52 Week Low
$60.56
$46.02
52 Week High
$89.29
$72.16

Technical Indicators

Market Signals
Indicator
HSIC
TECH
Relative Strength Index (RSI) 32.96 37.52
Support Level $70.67 $51.00
Resistance Level $74.85 $54.08
Average True Range (ATR) 1.91 2.32
MACD -0.77 -0.05
Stochastic Oscillator 9.56 31.01

Price Performance

Historical Comparison
HSIC
TECH

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: